IGM Biosciences Inc (FRA:1K0)
€ 13.9 -0.4 (-2.8%) Market Cap: 863.57 Mil Enterprise Value: 663.99 Mil PE Ratio: 0 PB Ratio: 7.62 GF Score: 29/100

Q4 2019 IGM Biosciences Inc Earnings Call Transcript

Mar 26, 2020 / 08:30PM GMT
Release Date Price: €42.8 (-6.55%)
Operator

Good day, everyone, and welcome to the IGM Biosciences Fourth Quarter and Full Year 2019 Financial Results. Today's call is being recorded.

At this time, I would now like to turn the call over to Misbah Tahir, Chief Financial Officer of IGM.

Misbah Tahir
IGM Biosciences, Inc. - CFO

Thank you, operator. Welcome, and thank you to those of you joining us today to discuss IGM's fourth quarter and full year 2019 financial results. With me this afternoon to discuss the financial results and to provide a general corporate update, are Fred Schwarzer, Chief Executive Officer; Bruce Keyt, Chief Scientific Officer; and Dan Chen, Chief Medical Officer.

Before we begin, please note that we will be making forward-looking statements on this call including statements about IGM's plans, expectations and forecasts and about future events. Actual results may differ materially as a result of various risks and uncertainties including those discussed in the company's most recent annual report on Form 10-K as well as its other filings with the SEC.

Any

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot